Topic: Breastcancer.org Podcasts: Listen to Experts Discuss

Forum: Mod Announcements, Breastcancer.org News, Blog Entries, Podcasts — Moderator generated forum to present our announcements or requests, organization and website news, blog entries and podcasts. Please do not post here if you are not a Moderator. Thank you!

Posted on: Dec 12, 2013 07:28AM - edited Oct 5, 2014 11:45AM by moderators

Posted on: Dec 12, 2013 07:28AM - edited Oct 5, 2014 11:45AM by moderators

moderators wrote:

Please go here to read about and listen to all our Podcasts! We will also be posting podcasts below as they air.

Note: Podcasts will be available in transcript form about 24 - 48 hours after the Podcasts have aired.

To send a PM to the Mods: community.breastcancer.org/my/...
Log in to post a reply

Page 25 of 25 (245 results)

Log in to post a reply

Oct 1, 2022 07:11AM moderators wrote:

Mental Health Benefits of Pets
Aug 19, 2022

Steven Feldman explains the science behind the benefits of pets.

We know that many people with breast cancer find that pets offer comfort and companionship and help them better cope with all the emotions that come with a cancer diagnosis and treatment. Steven Feldman joined us to talk about the mental health benefits pets can provide people with cancer, as well as things to think about if you're considering adopting a pet.

Listen to the episode to hear Steve talk about:

  • the benefits of pets
  • how pets affect people both physiologically and psychologically
  • things to consider before adopting a pet
Listen now or read the transcript.
To send a PM to the Mods: community.breastcancer.org/my/...
Log in to post a reply

Oct 1, 2022 07:11AM moderators wrote:

Enhertu for HER2-Low Breast Cancer: Patient-Reported Outcomes
Sep 14, 2022

Dr. Naoto Ueno discusses quality of life results from a study comparing Enhertu to doctors' choice of chemotherapy.

At the European Society for Medical Oncology Congress 2022, Dr. Naoto Ueno presented patient-reported quality-of-life outcomes from the DESTINY-Breast04 study, which found that compared to doctors' choice of chemotherapy, Enhertu (chemical name: fam-trastuzumab-deruxtecan-nxki) improved both progression-free survival and overall survival in people diagnosed with previously treated metastatic HER2-low breast cancer.

Listen to the episode to her Dr. Ueno explain:

  • how the researchers assessed quality of life
  • the results showing that Enhertu offered better quality of life than the doctors' choice of chemotherapy
  • differences in side effects between Enhertu and chemotherapy
Listen now or read the transcript.
To send a PM to the Mods: community.breastcancer.org/my/...
Log in to post a reply

Oct 1, 2022 07:12AM moderators wrote:

Trodelvy Offers Benefits for Hormone Receptor-Positive Breast Cancer
Sep 22, 2022

Dr. Hope Rugo discusses the latest results from the TROPiCS-02 trial showing Trodelvy improves overall survival compared to chemotherapy in metastatic, hormone receptor-positive, HER2-negative breast cancer.

At the European Society for Medical Oncology Congress 2022, Dr. Rugo presented results from the TROPiCS-02 trial, which was looking to see if the targeted therapy Trodelvy (chemical name: sacituzumab govitecan-hziy) could offer more benefits for people diagnosed with previously treated, metastatic, hormone receptor-positive, HER2-negative breast cancer than chemotherapy. Currently, Trodelvy is approved to treat previously-treated, metastatic triple-negative breast cancer.

Listen to the episode to hear Dr. Rugo explain:

  • the type of medicine Trodelvy is and how it works
  • the results showing people diagnosed with previously treated, metastatic, hormone receptor-positive, HER2-negative breast cancer lived longer when they received Trodelvy compared to chemotherapy
  • how the results from TROPiCS-02 fit into current treatment options
Listen now or read the transcript.
To send a PM to the Mods: community.breastcancer.org/my/...
Log in to post a reply

Oct 1, 2022 07:12AM moderators wrote:

Verzenio Improves Overall Survival in Hormone Receptor-Positive, HER2-Negative, Advanced Stage Breast Cancer
Sep 28, 2022

Dr. Matthew Goetz explains the latest results from the MONARCH 3 study on Verzenio.

At the European Society for Medical Oncology Congress 2022, Dr. Matthew Goetz presented interim overall survival results from the MONARCH 3 study showing that adding Verzenio to an aromatase inhibitor improves overall survival by 12.6 months for advanced-stage, hormone receptor-positive, HER2-negative breast cancer.

Listen to the podcast to hear Dr. Goetz explain:

  • how Verzenio works
  • the purpose of the MONARCH 3 study
  • the difference between progression-free and overall survival and why each is important
  • Verzenio side effects
  • what the results mean for people diagnosed with advanced-stage, hormone receptor-positive, HER2-negative breast cancer
Listen now or read the transcript.
To send a PM to the Mods: community.breastcancer.org/my/...
Log in to post a reply

Oct 1, 2022 07:12AM moderators wrote:

Paying for Breast Cancer Care
Sep 30, 2022

Joanna Morales and Loriana Hernandez-Aldama talk about the common issues people face when paying for cancer care and offer solutions for them.

Listen to the podcast to hear Joanna and Loriana discuss:

  • the four most common issues people face when paying for cancer care
  • their personal experiences helping people overcome financial issues
  • advice on how to solve financial issues
  • resource recommendations for help with financial issues
Listen now or read the transcript.
To send a PM to the Mods: community.breastcancer.org/my/...

Page 25 of 25 (245 results)

Scroll to top button